SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14C - Preliminary information statements relating to merger or acquisition:
SEC Accession No. 0001493152-24-007260
Filing Date
2024-02-20
Accepted
2024-02-20 17:22:48
Documents
3
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 formprem14c.htm PREM14C 1450965
2 ex107.htm EX-FILING FEES 14052
3 annexb_001.jpg GRAPHIC 4540
  Complete submission text file 0001493152-24-007260.txt   1472684
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14C | Act: 34 | File No.: 001-36138 | Film No.: 24655013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)